JP2004511469A5 - - Google Patents

Download PDF

Info

Publication number
JP2004511469A5
JP2004511469A5 JP2002534293A JP2002534293A JP2004511469A5 JP 2004511469 A5 JP2004511469 A5 JP 2004511469A5 JP 2002534293 A JP2002534293 A JP 2002534293A JP 2002534293 A JP2002534293 A JP 2002534293A JP 2004511469 A5 JP2004511469 A5 JP 2004511469A5
Authority
JP
Japan
Prior art keywords
alkyl
substituted
methyl
substituents
alkoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002534293A
Other languages
English (en)
Japanese (ja)
Other versions
JP4015548B2 (ja
JP2004511469A (ja
Filing date
Publication date
Priority claimed from GBGB0024795.7A external-priority patent/GB0024795D0/en
Application filed filed Critical
Publication of JP2004511469A publication Critical patent/JP2004511469A/ja
Publication of JP2004511469A5 publication Critical patent/JP2004511469A5/ja
Application granted granted Critical
Publication of JP4015548B2 publication Critical patent/JP4015548B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2002534293A 2000-10-10 2001-10-04 ウイルス性疾患の処置のためのピラゾール誘導体 Expired - Fee Related JP4015548B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0024795.7A GB0024795D0 (en) 2000-10-10 2000-10-10 Pyrazole derivatives for the treatment of viral diseases
PCT/EP2001/011474 WO2002030907A1 (en) 2000-10-10 2001-10-04 Pyrazole derivatives for the treatment of viral diseases

Publications (3)

Publication Number Publication Date
JP2004511469A JP2004511469A (ja) 2004-04-15
JP2004511469A5 true JP2004511469A5 (https=) 2005-04-14
JP4015548B2 JP4015548B2 (ja) 2007-11-28

Family

ID=9900999

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002534293A Expired - Fee Related JP4015548B2 (ja) 2000-10-10 2001-10-04 ウイルス性疾患の処置のためのピラゾール誘導体

Country Status (28)

Country Link
US (2) US6699887B2 (https=)
EP (1) EP1326843A1 (https=)
JP (1) JP4015548B2 (https=)
KR (1) KR100534158B1 (https=)
CN (2) CN1191239C (https=)
AR (1) AR030858A1 (https=)
AU (2) AU2002221651B2 (https=)
BR (1) BR0114483A (https=)
CA (1) CA2423515A1 (https=)
CZ (1) CZ20031297A3 (https=)
EC (1) ECSP034547A (https=)
GB (1) GB0024795D0 (https=)
GT (1) GT200100201A (https=)
HR (1) HRP20030251A2 (https=)
HU (1) HUP0302722A2 (https=)
IL (1) IL154875A0 (https=)
MA (1) MA26951A1 (https=)
MX (1) MXPA03003070A (https=)
NO (1) NO20031615L (https=)
NZ (1) NZ524740A (https=)
PA (1) PA8530301A1 (https=)
PE (1) PE20020750A1 (https=)
PL (1) PL362918A1 (https=)
RU (1) RU2270832C2 (https=)
UY (1) UY26956A1 (https=)
WO (1) WO2002030907A1 (https=)
YU (1) YU27203A (https=)
ZA (1) ZA200302519B (https=)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1335898B1 (en) * 2000-09-29 2005-11-23 TopoTarget UK Limited Carbamic acid compounds comprising an amide linkage as hdac inhibitors
GB0113524D0 (en) * 2001-06-04 2001-07-25 Hoffmann La Roche Pyrazole derivatives
JP2006504803A (ja) * 2002-09-26 2006-02-09 ファイザー・インク ピラゾール誘導体
EP1556381B1 (en) 2002-09-26 2008-02-20 Pfizer Limited Pyrazole amides for treating hiv infections
US7230025B2 (en) 2002-09-26 2007-06-12 Pfizer, Inc. Pyrazole derivatives
GB0223234D0 (en) * 2002-10-07 2002-11-13 Pfizer Ltd Chemical compounds
GB0223232D0 (en) * 2002-10-07 2002-11-13 Pfizer Ltd Chemical compounds
US6933312B2 (en) 2002-10-07 2005-08-23 Agouron Pharmaceuticals, Inc. Pyrazole derivatives
TW200423930A (en) * 2003-02-18 2004-11-16 Hoffmann La Roche Non-nucleoside reverse transcriptase inhibitors
CN100469769C (zh) * 2003-03-24 2009-03-18 弗·哈夫曼-拉罗切有限公司 作为逆转录酶抑制剂的苄基-哒嗪酮
US7220772B2 (en) 2003-09-05 2007-05-22 Pfizer, Inc. Pyrazole derivatives
WO2006004040A1 (ja) * 2004-07-01 2006-01-12 Daiichi Asubio Pharma Co., Ltd. Pde7阻害作用を有するチエノピラゾール誘導体
US20070005049A1 (en) * 2005-06-30 2007-01-04 Comben Richard H Apparatus and Method of Treating Urinary Incontinence by Heating Urethra
CN101511812A (zh) * 2006-07-05 2009-08-19 辉瑞产品公司 作为细胞色素p450抑制剂的吡唑衍生物
RU2451676C2 (ru) 2006-08-16 2012-05-27 Ф.Хоффманн-Ля Рош Аг Ненуклеозидные ингибиторы обратной транскриптазы
GB0713479D0 (en) * 2007-07-11 2007-08-22 Syngenta Participations Ag Substituted aromatic heterocyclic compounds as fungicides
WO2009080534A1 (en) 2007-12-21 2009-07-02 F. Hoffmann-La Roche Ag Heterocyclic antiviral compounds
GB0823000D0 (en) * 2008-12-17 2009-01-28 Syngenta Participations Ag Isothiazole and pyrazole derivatives with plant growth regulating properties
BRPI1008000A2 (pt) 2009-02-25 2016-02-23 Daiichi Sankyo Co Ltd composto, hidrobrometo, hidrocloreto, metanossulfonato, etano-1, 2-dissulfonato, inibidor de hsp90, agente para inibir a atividade de atpase de hsp90, agente para inibir a ligação de hsp90 em atp, medicamento, agente anticâncer, composição farmacêutica, método para tratar câncer, e, uso de um composto.
FR2951549B1 (fr) 2009-10-15 2013-08-23 Olivier Schussler Procede d'obtention de bioprotheses medicales implantables
TW201213334A (en) 2010-08-23 2012-04-01 Daiichi Sankyo Co Ltd Crystal forms of free form of tricyclic pyrazolopyrimidine derivative
EP2810945A1 (en) 2010-08-23 2014-12-10 Daiichi Sankyo Company, Limited Dihydrochloride salt of a tricyclic pyrazolopyrimidine derivative
WO2014074628A1 (en) * 2012-11-08 2014-05-15 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Compounds for treating hiv and methods for using the compounds
US9925190B2 (en) 2015-02-16 2018-03-27 University of Pittsburgh—of the Commonwealth System of Higher Education Small molecules targeting HIV-1 Nef
JP7301042B2 (ja) 2018-03-30 2023-06-30 住友化学株式会社 複素環化合物及びそれを含有する有害節足動物防除組成物
WO2020081856A1 (en) * 2018-10-18 2020-04-23 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Inhibitors of hiv-1 nef for the treatment of hiv disease
FR3121927B1 (fr) 2021-04-19 2023-03-31 Eiffage Genie Civil Terrassement Procédé d’inertage des boues d’excavation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993015060A1 (fr) 1992-01-22 1993-08-05 Nissan Chemical Industries, Ltd. Derive de pyrazole substitue et bactericide agrohorticole
TW336932B (en) * 1992-12-17 1998-07-21 Pfizer Amino-substituted pyrazoles
RU2130453C1 (ru) * 1992-12-17 1999-05-20 Пфайзер Инк. Замещенные пиразолы, фармацевтическая композиция на их основе, способ лечения, промежуточный продукт
CZ284157B6 (cs) * 1992-12-17 1998-08-12 Pfizer Inc. Pyrazolové a pyrazolopyrimidinové sloučeniny jako takové a pro léčbu chorob a farmaceutické prostředky na jejich bázi
US6005109A (en) 1997-10-30 1999-12-21 Pflizer Inc. Pyrazoles and pyrazolopyrimidines having CRF antagonistic activity
WO2006027423A1 (fr) * 2004-08-09 2006-03-16 Simag Developpement Dispositif de saisie comportant un capteur optique suivi d’un moyen de filtrage

Similar Documents

Publication Publication Date Title
JP2004511469A5 (https=)
RU2003112610A (ru) Производные пиразола для лечения вирксных заболеваний
JP2021119196A5 (https=)
JP2018535999A5 (https=)
JP2020516671A5 (https=)
JP2010505809A5 (https=)
JP2021501220A5 (https=)
JP2012528847A5 (https=)
JP2020521730A5 (https=)
RU2019118623A (ru) Пирролопиримидины в качестве потенциаторов мвтр
JP2008513514A5 (https=)
RU99126510A (ru) 3(5)-гетероарилзамещенные пиразолы в качестве ингибиторов киназы p38
NZ609955A (en) Sgc stimulators
JP2009536196A5 (https=)
RU2019132212A (ru) Селективные ингибиторы hdac6
JP2010502615A5 (https=)
JP2012525349A5 (https=)
JP2014524461A5 (https=)
RU2008141509A (ru) Mglur5 модуляторы 1
JP2006502112A5 (https=)
RU2010116352A (ru) Производные 1,1,1-трифтор-2-гидрокси-3-фенилпропана
JP2022508218A5 (https=)
JP2013531070A5 (https=)
JP2018534328A5 (https=)
JP2020520357A5 (https=)